Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes

Diabetes Care

Volumn 39, Issue 2, 2016, Pages 292-299

  Dadson, Prince ^a   Landini, Linda ^a,b   Helmiö, Mika ^b   Hannukainen, Jarna C ^a   Immonen, Heidi ^a,c   Honka, Miikka Juhani ^a   Bucci, Marco ^a   Savisto, Nina ^a   Soinio, Minna ^c   Salminen, Paulina ^c   Parkkola, Riitta ^c   Pihlajamäki, Jussi ^d   Iozzo, Patricia ^b   Ferrannini, Ele ^b   Nuutila, Pirjo ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; METFORMIN; PIOGLITAZONE; SULFONYLUREA DERIVATIVE; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MORBID OBESITY; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TREATMENT RESPONSE; WEIGHT REDUCTION; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY, MORBID; POSITRON-EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBCUTANEOUS FAT;

EID: 84962090340     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1447     Document Type: Article

References (40)

1. Bays HE, González-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6:343-368
2. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 1997;5:93-99
3. Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001;50:425-435
4. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-E948
5. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am JPhysiol Endocrinol Metab 2002;283:E1135-E1143
6. Lundbom J, Hakkarainen A, Lundbom N, Taskinen MR. Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue. Int J Obes 2013;37:620-622
7. Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005;183:13-30
8. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 1994;35:1490-1496
9. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990;10:493-496
10. Virtanen KA, Peltoniemi P, Marjamaki P, et al. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with mi-crodialysis. Diabetologia 2001;44:2171-2179
11. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576
12. Immonen H, Hannukainen JC, Iozzo P, et al. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2014;60:377-383
13. Helmiö M, Victorzon M, Ovaska J, et al. SLEEVEPASS: a randomized prospective multi-center study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc 2012;26:2521-2526
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl. 1):S5-S20
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223
16. Hill DL, Maurer CR Jr, Studholme C, Fitzpatrick JM, Hawkes DJ. Correcting scaling errors in tomographic images using a nine degree of freedom registration algorithm. J Com-put Assist Tomogr 1998;22:317-323
17. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584-590
18. Peltoniemi P, Lönnroth P, Laine H, et al. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 2000;279:E1122-E1130
19. Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002;87: 5044-5051
20. He Q, Engelson ES, Kotler DP. A comparison of abdominal subcutaneous adipose tissue pattern in obese and lean HIV-infected women. J Nutr 2005;135:53-57
21. Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol 2015;208: 501-512
22. Gray DS, Fujioka K, Colletti PM, et al. Magnetic-resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr 1991;54:623-627
23. Kim MK, Lee HC, Kwon HS, et al. Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery. Obesity (Silver Spring) 2011;19:1835-1839
24. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006;35:83-92
25. Kobayashi J, Maruyama T, Watanabe H, et al. Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population. Diabetes Res Clin Pract 2003;62:39-45
26. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-1693
27. Enevoldsen LH, Simonsen L, Stallknecht B, Galbo H, Bülow J. In vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous abdominal adipose tissue. Am J Physiol Endocrinol Metab 2001;281:E1110-E1114
28. Sadananthan SA, Prakash B, Leow MK, et al. Automated segmentation of visceral and subcutaneous (deep and superficial) adipose tissues in normal and overweight men. J Magn Reson Imaging 2015;41:924-934
29. Marinou K, Hodson L, Vasan SK, et al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care 2014;37: 821-829
30. Oliveira AL, Azevedo DC, Bredella MA, Stanley TL, Torriani M. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects. Obesity (Silver Spring) 2015;23:286-289
31. Virtanen KA, Iozzo P, Hällsten K, et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes 2005;54:2720-2726
32. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006;6:177-181
33. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010;11:11-18
34. Stolic M, Russell A, Hutley L, et al. Glucose uptake and insulin action in human adipose tissue-influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 2002;26:17-23
35. Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013;93:359-404
36. McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 2011;60:47-55
37. Hoffstedt J, Arner E, Wahrenberg H, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Dia-betologia 2010;53:2496-2503
38. Kang S, Kyung C, Park JS, et al. Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. Cardiovasc Diabetol. 2014;13:70
39. Torriani M, Zanni MV, Fitch K, et al. Increased FDG uptake in association with reduced extremity fat in HIV patients. Antivir Ther 2013; 18:243-248
40. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 2003;27(Suppl. 3): S6-S11